持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/06 | 3,245 | 3,280 | 3,240 | 3,270 | -5 | -0.2% | 38,300 |
| 2023/04/05 | 3,345 | 3,345 | 3,275 | 3,275 | -100 | -3% | 32,500 |
| 2023/04/04 | 3,370 | 3,395 | 3,340 | 3,375 | +30 | +0.9% | 32,400 |
| 2023/04/03 | 3,365 | 3,405 | 3,335 | 3,345 | +5 | +0.1% | 35,500 |
| 2023/03/31 | 3,325 | 3,365 | 3,320 | 3,340 | +35 | +1.1% | 29,000 |
| 2023/03/30 | 3,330 | 3,345 | 3,295 | 3,305 | -70 | -2.1% | 32,100 |
| 2023/03/29 | 3,370 | 3,395 | 3,340 | 3,375 | +30 | +0.9% | 57,300 |
| 2023/03/28 | 3,355 | 3,370 | 3,315 | 3,345 | +10 | +0.3% | 43,100 |
| 2023/03/27 | 3,325 | 3,350 | 3,300 | 3,335 | +40 | +1.2% | 42,800 |
| 2023/03/24 | 3,225 | 3,295 | 3,225 | 3,295 | +60 | +1.9% | 32,100 |
| 2023/03/23 | 3,250 | 3,260 | 3,230 | 3,235 | -55 | -1.7% | 38,300 |
| 2023/03/22 | 3,325 | 3,335 | 3,290 | 3,290 | +35 | +1.1% | 45,500 |
| 2023/03/20 | 3,350 | 3,355 | 3,255 | 3,255 | -115 | -3.4% | 35,000 |
| 2023/03/17 | 3,345 | 3,375 | 3,340 | 3,370 | +90 | +2.7% | 49,800 |
| 2023/03/16 | 3,280 | 3,310 | 3,250 | 3,280 | -40 | -1.2% | 52,300 |
| 2023/03/15 | 3,360 | 3,380 | 3,310 | 3,320 | -40 | -1.2% | 99,900 |
| 2023/03/14 | 3,390 | 3,405 | 3,320 | 3,360 | -100 | -2.9% | 48,200 |
| 2023/03/13 | 3,460 | 3,470 | 3,415 | 3,460 | ±0 | ±0% | 22,300 |
| 2023/03/10 | 3,520 | 3,535 | 3,455 | 3,460 | -95 | -2.7% | 50,300 |
| 2023/03/09 | 3,460 | 3,565 | 3,460 | 3,555 | +70 | +2% | 37,300 |
| 2023/03/08 | 3,470 | 3,510 | 3,470 | 3,485 | +15 | +0.4% | 34,500 |
| 2023/03/07 | 3,435 | 3,485 | 3,435 | 3,470 | +40 | +1.2% | 27,600 |
| 2023/03/06 | 3,475 | 3,475 | 3,415 | 3,430 | -45 | -1.3% | 34,000 |
| 2023/03/03 | 3,425 | 3,485 | 3,425 | 3,475 | +60 | +1.8% | 33,300 |
| 2023/03/02 | 3,390 | 3,425 | 3,380 | 3,415 | +40 | +1.2% | 30,800 |
| 2023/03/01 | 3,390 | 3,400 | 3,355 | 3,375 | -25 | -0.7% | 28,600 |
| 2023/02/28 | 3,440 | 3,460 | 3,390 | 3,400 | -20 | -0.6% | 36,500 |
| 2023/02/27 | 3,405 | 3,435 | 3,405 | 3,420 | +5 | +0.1% | 21,700 |
| 2023/02/24 | 3,385 | 3,425 | 3,355 | 3,415 | +30 | +0.9% | 35,500 |
| 2023/02/22 | 3,445 | 3,455 | 3,380 | 3,385 | -60 | -1.7% | 33,500 |
| 2023/02/21 | 3,415 | 3,445 | 3,405 | 3,445 | +25 | +0.7% | 20,000 |
| 2023/02/20 | 3,420 | 3,430 | 3,405 | 3,420 | +15 | +0.4% | 22,100 |
| 2023/02/17 | 3,425 | 3,440 | 3,405 | 3,405 | -50 | -1.4% | 15,600 |
| 2023/02/16 | 3,460 | 3,480 | 3,440 | 3,455 | +25 | +0.7% | 18,800 |
| 2023/02/15 | 3,445 | 3,455 | 3,430 | 3,430 | -5 | -0.1% | 16,400 |
| 2023/02/14 | 3,405 | 3,440 | 3,405 | 3,435 | +75 | +2.2% | 19,900 |
| 2023/02/13 | 3,360 | 3,390 | 3,345 | 3,360 | ±0 | ±0% | 17,200 |
| 2023/02/10 | 3,300 | 3,370 | 3,300 | 3,360 | +10 | +0.3% | 21,500 |
| 2023/02/09 | 3,360 | 3,385 | 3,345 | 3,350 | -20 | -0.6% | 16,800 |
| 2023/02/08 | 3,330 | 3,385 | 3,330 | 3,370 | +40 | +1.2% | 28,900 |
| 2023/02/07 | 3,415 | 3,440 | 3,315 | 3,330 | -100 | -2.9% | 36,400 |
| 2023/02/06 | 3,430 | 3,495 | 3,405 | 3,430 | +50 | +1.5% | 47,600 |
| 2023/02/03 | 3,415 | 3,425 | 3,375 | 3,380 | -55 | -1.6% | 22,600 |
| 2023/02/02 | 3,445 | 3,455 | 3,425 | 3,435 | -10 | -0.3% | 24,300 |
| 2023/02/01 | 3,505 | 3,505 | 3,445 | 3,445 | -35 | -1% | 25,900 |
| 2023/01/31 | 3,445 | 3,495 | 3,445 | 3,480 | +35 | +1% | 36,100 |
| 2023/01/30 | 3,420 | 3,470 | 3,420 | 3,445 | +25 | +0.7% | 33,500 |
| 2023/01/27 | 3,450 | 3,460 | 3,415 | 3,420 | -25 | -0.7% | 21,600 |
| 2023/01/26 | 3,475 | 3,475 | 3,440 | 3,445 | -5 | -0.1% | 33,000 |
| 2023/01/25 | 3,420 | 3,460 | 3,420 | 3,450 | +30 | +0.9% | 25,500 |
401～
450
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 330,500円 | +3.0% | +27.5% | 2.42% | 20.93倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 279,500円 | +52.1% | +23.3% | 0.00% | 19.84倍 | 3.81倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 469,500円 | +12.0% | +28.1% | 2.56% | 25.88倍 | 1.10倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 223,500円 | +13.6% | +29.2% | 2.06% | 11.59倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 114,000円 | +197.7% | - | 0.00% | 46.59倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
